跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Guselkumab Injection (Intravenous Infusion)
Approved
生物制品
Guselkumab Injection (Intravenous Infusion)
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Feb 20, 2025
Approval ID
8hPzCyWYkUl
Company
Janssen-Cilag International NV
Type
生物制品
Approval Details
Approval Id
8hPzCyWYkUl
Approval Number
国药准字SJ20250006
Generic Name
古塞奇尤单抗注射液(静脉输注)
Generic Name En
Guselkumab Injection (Intravenous Infusion)
Trade Name
特诺雅达
Drug Type
生物制品
Dosage Form
注射剂
Strength
200mg/20mL/瓶
Reg Date
2025-02-20
Expired Date
2030-02-19
Company Name
Janssen-Cilag International NV
Production Company Name
Cilag AG
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 20, 2025
Approval ID
8hPzCyWYkUl
Type
生物制品
Back to NMPA Approvals
特诺雅达 - NMPA Drug Approval Details
